Markets
News
Analysis
Tools
Learn
Stock
Score
Scan to Download
One power score. Smarter investment decisions
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Sign Up
Sign Up
Markets
/
Stocks
/
nasdaq-pbm
/
Psyence Biomedical Ltd
PBM
4.760
USD
-0.540
-10.19%
Close 09/19, 16:00(ET)
Quotes delayed by 15 min
USD
0.000
After-hours (ET)
106.63K
Market Cap
Loss
P/E TTM
Psyence Biomedical Ltd
4.760
-0.540
-10.19%
Overview
Company
Financials
Analysis
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Overview
Company
Financials
Analysis
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2024Q2
FY2024Q1
FY2023Q2
FY2023Q1
Operating expenses
-31.11%
176.16K
205.24%
1.29M
--
255.73K
--
421.51K
R&D expenses
--
--
392.45%
790.89K
--
1.94K
--
160.60K
Other operating expenses
--
-8.54K
--
8.53K
--
--
--
--
Operating profit
31.11%
-176.16K
-205.24%
-1.29M
--
-255.73K
--
-421.51K
Net non-operating interest income (expenses)
Gains from sale of securities
-6771.05%
-105.58K
-632.09%
-9.90K
--
-1.54K
--
-1.35K
Other non-operating income (expenses)
--
-8.54K
--
8.53K
--
--
--
--
Income before tax
-24.09%
-318.21K
-204.59%
-1.29M
--
-256.43K
--
-422.70K
Income after tax
-24.09%
-318.21K
-204.59%
-1.29M
--
-256.43K
--
-422.70K
Net income from continuous operations
-24.09%
-318.21K
-204.59%
-1.29M
--
-256.43K
--
-422.70K
Net income attributable to controlling interests
-24.09%
-318.21K
-204.59%
-1.29M
--
-256.43K
--
-422.70K
Net income attributable to common shareholders
-24.09%
-318.21K
-204.59%
-1.29M
--
-256.43K
--
-422.70K
Basic earnings per share
-24.07%
-1.78
-204.56%
-7.21
--
-1.44
--
-2.37
Diluted earnings per share
-24.07%
-1.78
-204.56%
-7.21
--
-1.44
--
-2.37
Dividend per share
--
0.00
--
0.00
--
0.00
--
0.00
Currency unit
USD
USD
USD
USD
Audit opinions
--
--
--
--
KeyAI
Please log in to use KeyAI
Log in
Sign Up